Rabies vaccine study for people with weak immune systems or older age
Part of Immune system & allergy, Infections clinical trials.
This study tests how well a rabies vaccine works and how safe it is for people whose immune systems may be weaker, such as those with certain long-term illnesses, organ transplants, or age 60 and older. It compares them to healthy adults ages 18 to 59.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been exposed to rabies (Category II or III) and need the vaccine after exposure.
- If you are age 18 to 59 and healthy, you can join the control group.
- If you have long-term immune system problems (like certain cancers, autoimmune diseases, or organ transplants), you may join the study group.
- If you have diabetes, chronic hepatitis, liver cirrhosis, kidney disease, or are age 60 or older, you may also join the study group.
- You must agree to follow the study schedule and sign a consent form.
- You cannot have had a rabies vaccine before or have HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different doses of a rabies vaccine to see how well they protect against rabies and how safe they are. It's for healthy adults who may need rabies protection, for example after an animal bite or as routine prevention.
This trial tests a freeze-dried rabies vaccine to see how safe it is when given on different schedules. It may be an option for people who need protection from rabies.
This study tests whether a single booster dose of the rabies vaccine is still effective in people who received the primary pre-exposure series several years ago. It compares three different vaccine regimens to see which one boosts immunity best.
This trial tests a new lyophilized rabies vaccine to see how well it works and how safe it is. It is for people who have not been vaccinated against rabies recently and have not been bitten or scratched by an animal that broke the skin in the past year.
This study tests a new rabies vaccine given after a possible exposure to rabies (like a bite) to see how well it works and how safe it is. The vaccine is given in a series of shots to help your body fight the rabies virus.
This trial tests a new freeze-dried rabies vaccine grown in human cells. It aims to confirm the vaccine is safe and works well for people aged 10 to 60 who have not been vaccinated against rabies before and have not been recently bitten by a rabid animal. By joining, you help ensure that a reliable vaccine is available to protect against this serious disease.
Hear when a new Immunocompromised trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.